Article Text

Download PDFPDF
Use of electronic cigarettes among young Swiss men
  1. Nedialka Douptcheva1,
  2. Gerhard Gmel2,
  3. Joseph Studer2,
  4. Stéphane Deline2,
  5. Jean-François Etter1
  1. 1 Faculty of Medicine, Institute of Social and Preventive Medicine, University of Geneva, Geneva, Switzerland
  2. 2 Alcohol Treatment Centre, Lausanne University Hospital CHUV, Lausanne, Switzerland
  1. Correspondence to Nedialka Douptcheva, Institut de médecine sociale et préventive, Université de Genève, CMU, 1 rue Michel-Servet, Genève 4 CH-1211, Switzerland; Nedialka.Douptcheva{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Electronic cigarettes have been recently gaining popularity, but there is little information on the public health implications of vaping or on the profile of vapers. The status of e-cigarettes in Switzerland was established in 20091 and the sales of e-cigarettes containing nicotine have been prohibited. However, the import of limited quantities of nicotine containing e-cigarettes and refill liquids for personal use is allowed. In this study, we describe the prevalence of e-cigarette use among young Swiss men and examine the associations between e-cigarette use and some characteristics of this population.

The analysis is part of the Cohort Study on Substance Use Risk Factors (C-SURF), a longitudinal study …

View Full Text


  • Contributors The listed authors have been credited with authorship based on the provided authorship criteria as follows: ND: conception, design, analysis and interpretation of the data, drafting of manuscript, final approval; GG: critical revision of manuscript, final approval; JS: acquisition of data, interpretation of data, final approval; SD: critical revision of manuscript, final approval; J-FE: Conception, design, interpretation of the data, critical revision of manuscript, final approval.

  • Funding This work was supported by Swiss National Science Foundation (grant 33CSC0-122679).

  • Competing interests Dr. Etter reports that he was reimbursed (plane + hotel) by a manufacturer of refill liquids for e-cigarettes, for traveling to London and to China, to visit e-cigarette factories. He was not paid for these meetings.

  • Ethics approval Ethics Committee for Clinical the Research of Lausanne University Medical School.

  • Provenance and peer review Not commissioned; internally peer reviewed.